|
ELK4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01882954797838E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.28289967327567E-10 |
| Normal-vs-Stage2 |
1.09409999948795E-07 |
| Normal-vs-Stage3 |
2.64870003707784E-09 |
| Normal-vs-Stage4 |
1.01629999971209E-07 |
| Stage1-vs-Stage2 |
3.366400E-01 |
| Stage1-vs-Stage3 |
1.449620E-01 |
| Stage1-vs-Stage4 |
4.568400E-01 |
| Stage2-vs-Stage3 |
9.200800E-01 |
| Stage2-vs-Stage4 |
8.310000E-01 |
| Stage3-vs-Stage4 |
7.234400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.61759502961922E-11 |
| Normal-vs-AfricanAmerican |
4.304300E-03 |
| Normal-vs-Asian |
3.8033999949505E-08 |
| Caucasian-vs-AfricanAmerican |
2.497600E-01 |
| Caucasian-vs-Asian |
4.069600E-01 |
| AfricanAmerican-vs-Asian |
9.932200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11270001493347E-09 |
| Normal-vs-Female |
2.93499669012931E-11 |
| Male-vs-Female |
1.779450E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59459999649059E-08 |
| Normal-vs-Age(41-60Yrs) |
5.83089132533132E-12 |
| Normal-vs-Age(61-80Yrs) |
5.18839970986562E-10 |
| Normal-vs-Age(81-100Yrs) |
6.156700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.123010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.727020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.719600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.765000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.409800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.485400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.055900E-02 |
| Classical-VS-Follicular |
6.557700E-03 |
| Classical-VS-Other |
6.436900E-03 |
| Classical-VS-Normal |
1.20010001936066E-09 |
| Tall-VS-Follicular |
5.963000E-01 |
| Tall-VS-Other |
4.685200E-01 |
| Tall-VS-Normal |
6.99089997002744E-09 |
| Follicular-VS-Other |
1.331000E-01 |
| Follicular-VS-Normal |
7.19899695411641E-11 |
| Other-VS-Normal |
2.70060000029382E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.19011525265978E-13 |
| Normal-vs-N1 |
2.1221000001681E-07 |
| N0-vs-N1 |
6.760000E-01 |
|
|
